Principles of pediatric combination vaccines and practical issues related to use in clinical practice

Pediatric Infectious Disease Journal

Volumn 20, Issue 11 SUPPL., 2001, Pages

  Decker, M D ^a  

^a NONE   (United States)

Author keywords

Combination; Pediatrics; Vaccines

Indexed keywords

ANTIGEN; CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS ACELLULAR PERTUSSIS HAEMOPHILUS INFLUENZAE TYPE B INACTIVATED POLIOMYELITIS VACCINE; DIPHTHERIA TETANUS ACELLULAR PERTUSSIS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA TETANUS ACELLULAR PERTUSSIS HEPATITIS B HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA TETANUS ACELLULAR PERTUSSIS HEPATITIS B INACTIVATED POLIOMYELITIS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA TETANUS ACELLULAR PERTUSSIS HEPATITIS B VACCINE; DIPHTHERIA TETANUS ACELLULAR PERTUSSIS INACTIVATED POLIOMYELITIS VACCINE; DIPHTHERIA TETANUS ACELLULAR PERTUSSIS VACCINE; DIPHTHERIA TETANUS HEPATITIS B VACCINE; DIPHTHERIA TETANUS INACTIVATED POLIOMYELITIS VACCINE; DIPHTHERIA TETANUS PERTUSSIS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA TETANUS PERTUSSIS HAEMOPHILUS INFLUENZAE TYPE B INACTIVATED POLIOMYELITIS VACCINE; DIPHTHERIA TETANUS PERTUSSIS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA TETANUS PERTUSSIS HEPATITIS B VACCINE; DIPHTHERIA TETANUS PERTUSSIS INACTIVATED POLIOMYELITIS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS B INACTIVATED POLIOMYELITIS VACCINE; INACTIVATED VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; TETANUS TOXOID INACTIVATED POLIOMYELITIS VACCINE; TRIAVAC; TRIHIBIT; TRIPACEL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE;

ANTIBODY TITER; ARTICLE; CLINICAL PRACTICE; DRUG EFFICACY; DRUG SAFETY; DRUG STORAGE; DRUG UTILIZATION; EVALUATION; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNE RESPONSE; INJECTION; LICENSING; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIDE EFFECT; VACCINATION;

CLINICAL TRIALS; HUMANS; IMMUNIZATION SCHEDULE; PEDIATRICS; SAFETY; VACCINES, COMBINED;

EID: 0035163920     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200111001-00002     Document Type: Article

References (56)

1. Physician and parent opinions: Are children becoming pincushions from immunizations?
2. Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV): A meeting report of the WHO Programme for Vaccine Development
3. Future vaccines and a global perspective
4. Glycoconjugate vaccines: Future combinations
5. Missed opportunities for vaccination and the delivery of preventive care
6. The measles epidemic
7. Issues in design of clinical trials of combination vaccines
8. Combination vaccines consisting of acellular pertussis vaccines
9. Combination vaccines: Hopes and challenges
10. Combination vaccines
11. Simultaneous administration of childhood vaccines: An important public health policy that is safe and efficacious
12. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine
13. The vaccines event report sytem (VERS)
14. Prevention Recommended childhood immunization schedule
15. Safety and immunogenicity of acellular diphtheria-tetanuspertussis and Haemophilus conjugate vaccines given in combination or at separate injection sites
16. Immunogenicity of a combined DTPaPRP-D conjugate vaccine compared to separate injections in infants
17. Safety and immunogenicity of DTPa-HbOC: A combined oligosaccharide conjugate (HbOC, HibTITER) Haemophilus influenzae type b and acellular DTP vaccine (DTPa) in toddlers
18. Antibodies to pertussis induced by DTPa and HbOC administered simultaneously vs combined in children <15 months vs ≥15 months
19. Safety of combined acellular pertussis DTPa-HbOC vaccine (Lederle-Praxis) in infants
20. TriHIBit monograph
21. Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants
22. Hib antibody response of a combined DTPaPRP-T conjugate vaccine compared to separate injections in infants
23. Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T)
24. Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTPa) combination vaccine administered to infants in Belgium and Turkey
25. Immunogenicity and reactogenicity of 2 Hib tetanus conjugate vaccines administered by reconstituting with DTPa or given as separate injections
26. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus toxoid and acellular pertussis vaccine for primary and for booster immunizations
27. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTPa) when combined with a Haemophilus influenzae type btetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants
28. Primary vaccination of infants with a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine
29. Feasibility study of a combined diphtheria-tetanus-acellular pertussishepatitis B (DTPa-HepB) vaccine, and comparison of clinical reactions and immune responses with diphtheria-tetanusacellular pertussis (DTPa) and hepatitis B vaccines applied as mixed or injected into separate limbs
30. Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules
31. Safety and immunogenicity of a combination DTPa-hepatitis B vaccine (DTPa-Hep B) administered to infants at 2, 4 and 6 months of age
32. The way forward: Combined vaccines
33. Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine
34. Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine
35. Evaluation of the reactogenicity and immunogenicity of a new combined DTPa-HBV-IPV vaccine co-administered with Hib vaccine at 2, 4, and 6 months of age
36. A randomized study of the safety and immunogenicity of DTPa-HepB-IPV vaccine administered as three doses or in a sequential IPV/OPV schedule at 2, 4, and 6 months of age
37. Reactogenicity of a new pentavalent combination, DTPa-HBV-IPV administered with Hib vaccine, in comparison with widely used commercial vaccines in 5472 subjects
38. Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants
39. Primary vaccination of infants with diphtheriatetanus- acellular pertussis-hepatitis B virus-inactivated powlio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections
40. A combination DTPa-HepB-IPV/Hib vaccine administered to infants at 2, 4, and 6 months of age with or without a hepatitis B vaccine birth dose
41. Combination vaccines for childhood immunization
42. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants
43. Practical considerations regarding the impact on immunization schedules of the introduction of new combined vaccines
44. Prevention General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
45. Pertussis vaccination: Use of acellular pertussis vaccines among infants and young children
46. Prevention of pneumococcal disease
47. Diphtheria and pertussis: Recommendations for vaccine use and other preventive measures
48. Extensive swelling after booster dose of acellular pertussis-tetanusdiphtheria vaccines
49. Inadequate history as a barrier to immunization
50. Requirements for permanent vaccination records and for reporting of selected events after vaccination
51. Beliefs and practices regarding childhood vaccination among urban pediatric providers in New Jersey
52. Vaccine registries are useful despite data entry errors
53. Too many shots?: Parent, nurse, and physicians attitudes toward multiple simultaneous childhood vaccinations
54. Multiple immunizations: Ouch!
55. Barriers to measles and pertussis immunization: The knowledge and attitudes of Pennsylvania primary care physicians
56. Immunization opportunities missed among urban poor children